Development of a Clinical and Biological Database Monocentric and Prospective in Peritoneal Carcinosis
Overview
- Phase
- Not Applicable
- Intervention
- biological collection
- Conditions
- Cancer
- Sponsor
- Institut du Cancer de Montpellier - Val d'Aurelle
- Enrollment
- 600
- Locations
- 1
- Primary Endpoint
- Proportion of patients who gave their consent to participate in the study
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
The creation of a prospective clinical-biological base dedicated to peritoneal carcinosis must therefore be able to serve as a support for this essential search for transfer.
Detailed Description
The main objective is to improve the knowledge of carcinosis mechanisms to develop a specific treatment. That's why this blood collection and tissue collection is very important for the future, these collection will be permitted to the scientists to develop a research specially for carcinosis.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patient over the age of 18;
- •Patient managed for peritoneal carcinosis : digestives origins (pancreatic, gastroesophageal junction, colorectal, bowel) or peritoneum cancer
- •Patient eligible for a peritoneal carcinosis treatment : at least one (or more) surgery (s) ;chemotherapy or any treatment for this disease
- •Patient agree will all study procedure : biological samples \& tissues samples
- •Patient giving informed consent
Exclusion Criteria
- •Patient not affiliated to Social Protection system
- •Patient unable to understand or comply with study instructions or requirements for psychological, family, social or geographical reasons
- •The level of French is insufficient to consent to the study and to response to the questionnaires
- •Patient under guardianship
- •Pregnancy ou breast-feeding women
- •Patient treated in case of an emergency
Arms & Interventions
Tumors and blood collection
For all the patients include in the study : * Blood samples will be collected at different times : before any treatment, at every surgery, one month after any surgery, at progression. * Tumours and not tumours tissues will be collected at different times : Before any surgery, one month after any surgery In parallel to this biological collection, standardized clinical data will be entered into a database treatment, at every surgery
Intervention: biological collection
Tumors and blood collection
For all the patients include in the study : * Blood samples will be collected at different times : before any treatment, at every surgery, one month after any surgery, at progression. * Tumours and not tumours tissues will be collected at different times : Before any surgery, one month after any surgery In parallel to this biological collection, standardized clinical data will be entered into a database treatment, at every surgery
Intervention: Tissues collections
Outcomes
Primary Outcomes
Proportion of patients who gave their consent to participate in the study
Time Frame: Until the study completion: 4 years
The proportion of patients who consent to participate in the study among the screened patients